Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CACNA1G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR51B5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725451 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF518B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105376100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37A7P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIXL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NALCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on